Carregant...
Oridonin Sensitizes Hepatocellular Carcinoma to the Anticancer Effect of Sorafenib by Targeting the Akt Pathway [Corrigendum]
Guardat en:
| Publicat a: | Cancer Manag Res |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Dove
2021
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7991195/ https://ncbi.nlm.nih.gov/pubmed/33776476 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CMAR.S310256 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|